Solco-Urovac

Solco-Urovac
Vaccine description
TargetEscherichia coli (4 strains), Klebsiella pneumoniae, Proteus mirabilis, Proteus morganii, and Enterococcus faecalis
Vaccine typeInactivated
Clinical data
Trade namesSolco-Urovac; Strovac
Routes of
administration		Vaginal (suppository); Parenteral

Solco-Urovac (vaginal suppository), also known as Strovac (parenteral), is a vaccine against urinary tract infections (UTIs). It contains 10 strains of bacteria known to cause UTIs, including four strains of Escherichia coli as well as Klebsiella pneumoniae, Proteus mirabilis, Proteus morganii, and Enterococcus faecalis. The vaccine is administered weekly for 3 weeks, with an optional monthly booster for 3 months.

See also

References

  1. 1 2 3 4 5 6 Doiron RC, Cotechini T, Nickel JC (June 2024). "It's Time to Embrace Vaccination as We Enter the Postantibiotic Era of Recurrent Urinary Tract Infection Management". The Journal of Urology. 211 (6): 797–799. doi:10.1097/JU.0000000000003969. PMID 38704743.
  2. ↑ Mak Q, Greig J, Dasgupta P, Malde S, Raison N (September 2024). "Bacterial Vaccines for the Management of Recurrent Urinary Tract Infections: A Systematic Review and Meta-analysis". European Urology Focus. 10 (5): 761–769. doi:10.1016/j.euf.2024.04.002. PMID 38644097.